Citigroup
ONC

Citigroup’s BeOne Medicines Ltd ONC Stock Holding History

Citigroup’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.99M Hold
14,000
– – ﹤0.01% 2339
2026
Q1 		$4.16M Sell
14,000
-6,000
-30% -$1.94M ﹤0.01% 2110
2025
Q4 		$6.08M Hold
20,000
– – ﹤0.01% 1880
2025
Q3 		$6.81M Buy
+20,000
New +$6.07M ﹤0.01% 1769
2025
Q1 		– Sell
-29,900
Closed -$5.52M – 6063
2024
Q4 		$5.52M Buy
+29,900
New +$6.11M ﹤0.01% 1857
2024
Q3 		– Sell
-15,000
Closed -$2.14M – 5829
2024
Q2 		$2.14M Buy
+15,000
New +$2.31M ﹤0.01% 2295

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citigroup's ONC Position: Q2 2026 in Review

Citigroup reduced its BeOne Medicines Ltd (ONC) stake by 52% in Q2 2026, selling an estimated $1.57M and leaving 4,860 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #3214.

Citigroup first reported a position in ONC in Q1 2016 and has held it in 40 quarters since. The position peaked at $21.9M in Q3 2018. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Citigroup held 4,860 shares of BeOne Medicines Ltd worth $1.38M as of Q2 2026.
  • Citigroup sold 5,328 BeOne Medicines Ltd shares in Q2 2026, an estimated $1.57M.
  • BeOne Medicines Ltd made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3214 holding.
  • Citigroup first reported a position in BeOne Medicines Ltd in Q1 2016 and has held it in 40 quarters since.
  • Citigroup's BeOne Medicines Ltd position peaked at $21.9M in Q3 2018.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.